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Crescentic glomerulonephritis is mediated by inappropriate
humoral and cellular immune responses toward self-antigens
that may result from defects in central and peripheral
tolerance. Evidence now suggests that regulatory T cells
(Tregs) may be of pathophysiological importance in
proliferative and crescentic forms of glomerulonephritis.
To analyze the role of endogenous Tregs in a T cell-
dependent glomerulonephritis model of nephrotoxic
nephritis, we used ‘depletion of regulatory T cell’ (DEREG)
mice that express the diphtheria toxin receptor under control
of the FoxP3 (forkhead box P3) gene promoter. Toxin
injection into these mice efficiently depleted renal and
splenic FoxP3þ Treg cells as determined by fluorescent-
activated cell sorting (FACS) and immunohistochemical
analyses. Treg depletion exacerbated systemic and renal
interferon-c (IFNc) expression and increased recruitment of
IFNc-producing Th1 cells into the kidney without an effect on
the Th17 immune response. The enhanced Th1 response,
following Treg cell depletion, was associated with an
aggravated course of glomerulonephritis as measured by
glomerular crescent formation. Thus, our results establish the
functional importance of endogenous Tregs in the control of
a significantly enhanced systemic and renal Th1 immune
response in experimental glomerulonephritis.
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Crescentic glomerulonephritis is mediated by inappropriate
humoral and cellular immune responses toward not well-
characterized (self) antigens that might result from defects in
central and peripheral tolerance. CD4þCD25þFoxP3þ
regulatory T cells (Tregs) are generally thought to be of
critical importance for the maintenance of peripheral
tolerance.1 Until now, little is known about the suppressive
mechanisms mediated by CD4þCD25þFoxP3þ Tregs and
their behavior during proliferative and crescentic glomer-
ulonephritis.2,3 With respect to human disease, one report
indicates that CD25þ T cells emerge following acute episodes
of Goodpasture’s disease suppressing the response to the
Goodpasture autoantigen.4 Furthermore, the potential
of Tregs to suppress the pathogenic immune responses in
kidney disease has recently been proven in a model of
crescentic glomerulonephritis in mice. The adoptive transfer
of CD4þCD25þ Tregs showed that Tregs downregulate the
nephritogenic immune response directly at the systemic site
of antigen-specific T-cell priming, namely the renal lymph
node.5 In consecutive studies, Eller et al.6 demonstrated that
the chemokine receptor CCR7 (chemokine (C-C motif)
receptor 7) regulates the trafficking of Tregs to the lymph
node in experimental glomerulonephritis, which is essential
for their anti-inflammatory properties. Our group recently
provided evidence that Treg cells migrate in a CCR6–CCL20-
dependent manner into the inflamed kidney in crescentic
glomerulonephritis and might locally suppress immune-
mediated renal inflammation.7
This study was designed to examine the potential role
of endogenous Tregs in crescentic glomerulonephritis.
We therefore induced the T cell-dependent model of
nephrotoxic nephritis (NTN) in ‘depletion of regulatory
T cell’ (DEREG) mice that express the diphtheria toxin
(DTx) receptor and green fluorescent protein (GFP) under
control of the FoxP3 (forkhead box P3) promoter, allowing
selective and efficient depletion of FoxP3þ Treg cells by
DTx injection.8 Hence, we intended to address whether
Treg depletion influences the clinical course of experimental
glomerulonephritis, and if so, to study their potential
mechanisms of action.
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RESULTS
Functional involvement of endogenous Tregs in NTN
To investigate the role of endogenous Tregs, we determined
the frequency of CD4þCD25þFoxP3þ Tregs upon induc-
tion of NTN in a time course experiment. Interestingly, the
number of Tregs was increased from day 5 onward, as shown
by immunohistological FoxP3 staining (Figure 1a and b).
To evaluate the immunosuppressive capacity of Tregs from
nephritic mice compared with their counterparts from healthy
control mice, we isolated splenic CD4þCD25þ Tregs from
both nephritic and healthy control mice and performed T-cell
co-culture experiments. Enzyme-linked immunosorbent assay
(ELISA) analysis of supernatants from co-cultures of Tregs and
CD4þCD25 responder T cells indicated that Tregs from
nephritic mice maintained their in vitro suppressive capacity
and might be even more potent than Tregs from healthy
controls to inhibit the production of interleukin (IL)-2 and
interferon-g (IFNg) by responder T cells (Figure 1c, IL-2
(pg/ml): single culture of responder T cells: 334.3±22.0;
responder T cellsþTregs (control): 79.3±10.5; responder
T cellsþTregs (NTN): 43.7±13.5; ***Po0.0001; IFNg
(pg/ml): single culture of responder T cells: 8490±772,
responder T cellsþTregs (control): 6084±2949, responder
T cellsþTregs (NTN): 4137±845.2; *Po0.05).
Depletion of Tregs in DEREG mice by injection of DTx
To examine the involvement of endogenous Tregs in the
model of crescentic glomerulonephritis, we used C57BL/6
DEREG mice in which specific depletion of FoxP3þ Tregs by
injection of DTx and tracking of green fluorescent Tregs
by fluorescent-activated cell sorting (FACS) analysis can be
performed. To assess the efficiency of Treg depletion after
repetitive injection of 1 mg DTx per mouse (day 1 and day 3
upon NTN induction), FoxP3 expression was quantified in
spleen and kidney at 7 days after NTN induction. Indeed,
frequency of CD4þFoxP3þ Tregs was significantly reduced
in both spleen (Figure 2a; 7.8 vs o1%) and kidney tissue
(Figure 2b; 20.1 vs 2.6%) of DTx-treated mice in contrast to
control nephritic mice as shown by intracellular FoxP3
staining with subsequent FACS analysis. GFP expression was
also reduced in accordance to FoxP3 expression (data not
shown). Successful renal Treg depletion was confirmed by
histological staining of FoxP3 (Figure 2c). The frequency of
Tregs was significantly reduced by B80% at 4 days after the
second DTx challenge (Figure 2d: FoxP3þ Tregs (cells per
low power field): 24.7±2.7 vs 5.3±1.5; **Po0.01).
Aggravated NTN in Treg-depleted nephritic mice
Next, we induced NTN in C57BL/6 wild-type (wt) and
DEREG mice with and without Treg depletion. Examination
of periodic acid-Schiff (PAS)-stained kidney sections in the
T cell-mediated autologous phase at day 7 after injection
of the nephritogenic sheep serum revealed glomerular
and tubulointerstitial damage. First, PAS-positive material
was deposited intraglomerularly. Moreover, formation of
cellular crescents and hypercellularity account for glomerular
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Figure 1 | Endogenous regulatory T cells (Tregs) in the murine model of nephrotoxic nephritis (NTN). (a) Representative
immunohistochemistry for Tregs (forkhead box P3 (FoxP3)) in kidney sections from nephritic mice and nonnephritic controls (original
magnification  400). (b) Quantification of tubulointerstitial FoxP3þ T-cell infiltration per low power field (lpf; original magnification  100)
during the time course of NTN (nX4). (c) 1 105 Splenic CD4þCD25 responder T cells were cultured without or with 1 105 splenic
CD4þCD25þ Tregs from nonnephritic wild-type (wt) controls or nephritic wt mice and stimulated with plate-bound anti-CD3 monoclonal
antibody (mAb) for 72 h. Secretion of the cytokines interleukin-2 (IL-2) and interferon-g (IFNg) was assessed in supernatants by enzyme-
linked immunosorbent assay (ELISA; *Po0.05, ***Po0.0001).
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alterations (Figure 3a). In the tubulointerstitial compartment,
aberrant leukocyte infiltration and focal destruction of the
regular tissue structure were detectable indicated by tubular
dilatation and intratubular protein casts (data not shown).
To quantify glomerular and tubular tissue damage, PAS-
stained kidney sections were evaluated as previously de-
scribed.7 The frequency of glomerular crescent formation on
day 7 of NTN was significantly increased in Treg-depleted
DEREG mice compared with nephritic DEREG mice without
DTx injection (Figure 3b (%): wtþDTx: 1.7±1.7, DE-
REGþDTx: 1.7±1.0, wt NTN: 16.1±3.2, DEREG NTN:
16.1±3.2, wt NTNþDTx: 15.0± 3.3, DEREG NTNþDTx:
29.5±3.6; *Po0.05). As a measure of tubulointerstitial
injury, an increase of the interstitial area estimated by point
counting was observed in all nephritic groups. It did,
however, not reveal differences with respect to Treg depletion
(data not shown). The same results were obtained for
urinary albumin/creatinine ratio (DEREG NTN vs DEREG
NTNþDTx: 136.4±15.8 vs 133.7±19.6). Furthermore,
blood urea nitrogen was elevated in all nephritic groups
compared with controls, with a tendency to a further increase
in Treg-depleted mice (Figure 3c (mg/dl): DEREG NTN vs
DEREG NTNþDTx: 47±5.6 vs 57.9±10.4; P¼ 0.33).
Increased renal T-cell and macrophage/monocyte/dendritic
cell (DC) recruitment in Treg-depleted nephritic mice
To investigate the role of Tregs regarding recruitment of
T effector cells into the inflamed kidney, we performed
immunohistological stainings of kidney sections for the pan
T-cell marker CD3 in Treg-depleted and nondepleted
nephritic DEREG and wt mice (Figure 4a). At 7 days after
induction of NTN, nephritic mice showed an increased renal
infiltration of CD3þ T cells, predominantly in the interstitial
and periglomerular area. Moreover, the frequency of intraglo-
merular T cells in nephritic mice was increased compared with
nonnephritic controls. Interestingly, T-cell infiltrates in Treg-
depleted nephritic mice were significantly increased in contrast
to nondepleted nephritic mice (Figure 4b (cells per high power
field): wtþDTx: 13.0±2.0, DEREGþDTx: 22.7±1.3, wt
NTN: 22.5±6.0, DEREG NTN: 32.5±5.4, wt NTNþDTx:
23.5±3.6, DEREG NTNþDTx: 62.3±10.4; *Po0.05). This
suggests an important role of Tregs regarding inhibition of
T effector cell recruitment into the inflamed kidney. We also
analyzed the number of F4/80þ macrophages/monocytes and
DCs in kidney sections of healthy control and nephritic mice
with and without Treg depletion (Figure 4c). Similarly, we
detected a general increase of macrophage/monocyte/DC
infiltrates in nephritic mice in contrast to the healthy control
group. Treg depletion resulted in further enhancement of
macrophage/monocyte/DC recruitment into the kidney (Figure
4d (cells per high power field): wtþDTx: 9.0±1.5, DE-
REGþDTx: 10.7±1.7, wt NTN: 14.0±2.6, DEREG NTN:
26.3±3.6, wt NTNþDTx: 17.3±1.9, DEREG NTNþDTx:
42.3±5.3; *Po0.05).
Upregulation of renal IFNc response upon Treg depletion and
NTN induction
To assess the renal T helper cell response on day 7 upon NTN
induction, we first isolated RNA from renal cortex of
nephritic DEREG and wt mice as well as the corresponding
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Figure 2 |Depletion of regulatory T cells (Tregs) in DEREG (depletion of regulatory T cell) mice by diphtheria toxin (DTx). Systemic
depletion of Tregs was monitored by fluorescent-activated cell sorting (FACS) analysis of (a) splenic and (b) renal CD4þ T cells isolated from
DEREG mice 7 days after induction of nephrotoxic nephritis (NTN) and 4 days after second application of DTx. (c) Representative kidney
sections from nephritic DEREG mice without and with DTx treatments show FoxP3þ staining. (d) Quantification of renal and splenic FoxP3þ
T cells indicates a strong reduction in numbers of FoxP3þ T cells after DTx treatments (**Po0.01).
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controls and measured the expression of Th1 and Th17
effector cytokines. IFNg mRNA expression was significantly
upregulated in kidney tissue of Treg-depleted nephritic
DEREG mice in contrast to nondepleted nephritic mice
(Figure 5a: IFNg: wtþDTx: 0.8±0.1, DEREGþDTx: 2.0±
0.8, wt NTN: 1.0±0.2, DEREG NTN: 1.1±0.3, wt NTNþ
DTx: 1.4±0.2, DEREG NTNþDTx: 7.0±1.6; ***Po0.0001).
IL-17 was generally upregulated in nephritic mice. However, in
contrast to IFNg, renal expression of IL-17 was unchanged in
Treg-depleted and nondepleted nephritic mice (Figure 5a). The
increased IFNg expression induced by ablation of Tregs
correlated with elevated CXCL10 (chemokine (C-X-C motif)
ligand 10) expression (data not shown), one of the ligands for
CXCR3 (chemokine (C-X-C motif) receptor 3) receptors that
mainly mediate the migration of Th1 cells into the kidney.9
To verify the Treg-mediated suppression of IFNg
responses, we performed intracellular cytokine staining in
renal CD4þ T cells from control and nephritic mice after
in vitro stimulation with phorbol 12-myristate 13-acetate/
ionomycin. Corresponding to the elevated IFNg mRNA
expression in kidney tissue, the IFNg protein expression was
strongly increased in renal T cells isolated from Treg-depleted
nephritic mice compared with nondepleted nephritic mice
(Figure 5b: 43.6 vs 17.4%). Again, protein expression of IL-17
remained nearly unchanged between 2 and 3% in all groups
of nephritic mice (Figure 5b). Quantification of three
independent FACS analyses displayed a significant increase
of IFNg- but not IL-17-producing CD4þ T cells in Treg-
depleted nephritic DEREG mice in contrast to nondepleted
nephritic DEREG or wt mice (Figure 5c: IFNgþCD4þ T cells
(%): wt NTN: 17±1.4, DEREG NTN: 15.8±1.4, wt
NTNþDTx: 18.5±0.7, DEREG NTNþDTx: 35.5±4.3;
***Po0.0001).
To evaluate whether the absence of Tregs during the
induction phase of nephritis is sufficient for the aggravated
phenotype in Treg-depleted mice, we directly compared a
single injection of DTx on day –1 with the continuous Treg
depletion (days –1 and 3; Supplementary Figure S1 online).
Interestingly, early depletion of Tregs resulted in a sustained
reduction of splenic Tregs from 16.7 to 5.9% up to day 7,
whereas a double DTx injection was necessary for complete
depletion of splenic Tregs (Supplementary Figure S1A online:
CD4þFoxP3þGFPþ T cells (%): 16.7±0.75 vs 2.9±0.5;
***Po0.0001). Accordingly, glomerular damage was only
slightly elevated in mice with a single early depletion but was
considerably aggravated in continuously depleted mice
(Supplementary Figure S1B online).
Augmented systemic immune response in Treg-depleted
nephritic mice
To investigate the role of endogenous CD4þCD25þFoxP3þ
Tregs regarding the systemic immune response in the mouse
model of NTN, splenocytes were isolated from wt and
DEREG mice 7 days after induction of NTN and stimulated
in vitro with sheep immunoglobulin G (IgG), the nephrito-
genic antigen. Consistent with the results obtained in the
inflamed target organ, namely in the kidney, ELISA analysis
of splenocyte supernatants indicated that Treg depletion in
nephritic mice resulted in an increased systemic IFNg
secretion compared with NTN mice without Treg depletion
(Figure 6a, IFNg (pg/ml): wtþDTx: 1.0±0.02,
DEREGþDTx: 1.0±0.02, wt NTN: 421.0±54.5, DEREG
NTN: 608.7±37.2, wt NTNþDTx: 307.0±37.9, DEREG
NTNþDTx: 3457.0±175.8; ***Po0.0001). IL-17 secretion
by splenocytes from mice with NTN was not elevated in Treg-
depleted nephritic mice (Figure 6a, IL-17 (pg/ml): wtþDTx:
1.0±0.02, DEREGþDTx: 1.0±0.02, wt NTN: 39.3±3.7,
DEREG NTN: 45.7±3.8, wt NTNþDTx: 60.8±3.0, DEREG
NTNþDTx: 25.0±2.1; ***Po0.0001).
Moreover, systemic humoral immune responses to sheep
IgG are important for initiation of the autologous phase of
NTN. Hence, we determined the IgG antibody response
directed against the nephritogenic antigen in serum samples
by ELISA for sheep IgG-specific mouse IgG subclasses.
Depletion of Tregs resulted in significantly increased levels of
total IgG and the isotypes of IgG1, IgG2a/c,10 and IgG2b
(Figure 6b).
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Figure 3 |Aggravated nephrotoxic nephritis (NTN) in
regulatory T cell (Treg)-depleted DEREG (depletion of
regulatory T cell) mice. (a) Representative photographs of
periodic acid-Schiff (PAS)-stained kidney sections of control mice
(wild-type (wt)þdiphtheria toxin (DTx)) and nephritic wt or
DEREG mice without or with DTx treatment (original
magnification  400) on day 7 after induction of NTN.
(b) Quantification of glomerular crescents (*Po0.05) was
performed. (c) Blood urea nitrogen (BUN) was determined.
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Furthermore, we performed immunohistochemical stain-
ing of kidney sections for sheep IgG (Supplementary Figure
S2A online) and mouse IgG (Supplementary Figure S2B
online) to evaluate the amount of antibody deposition in
injured glomeruli. Semiquantitative assessment of mouse
IgG-stained sections revealed that discrete granular mouse
IgG immune deposit within the glomeruli were increased in
nephritic mice but were not further elevated in nephritic
Treg-depleted mice compared with nephritic mice without
depletion (Supplementary Figure S2B online).
Reduced disease severity in Treg-depleted nephritic mice
upon anti-IFNc treatment
To investigate the role of endogenous Tregs regarding Treg-
mediated suppression of Th1 immune responses, we
inhibited the Th1-specific IFNg response by injection of an
anti-IFNg antibody together with the first DTx dose at 1 day
before NTN induction in DEREG mice. Indeed, aggravation
of glomerular damage as measured by a significant increase of
crescent formation in Treg-depleted nephritic controls was
significantly inhibited in Treg-depleted, anti-IFNg-treated
nephritic mice (Figure 7a (%): wt: 1.1±0.6, DEREG NTN:
27±1.3, DEREG NTNþDTx: 39.5±4.2, DEREG NTNþ
aIFNg: 19.5±2.3, DEREG NTNþDTxþ aIFNg: 26.3±1.4;
**Po0.01). However, blood urea nitrogen was elevated in all
nephritic groups compared with controls, but did not show a
significant reduction in anti-IFNg-treated mice (Figure 7b).
FACS analysis of renal T cells indicated that anti-IFNg
treatment reversed the enhanced frequency of IFNg-produ-
cing CD4þ Th1 cells in Treg-depleted nephritic mice on
day 7 upon NTN induction (Figure 7c; 28.6 vs 48%).
Concordantly, renal expression of T-bet, a Th1-specific
transcription factor, as well as of the IFNg-inducible
chemokine CXCL10, which recruits CXCR3þ Th1 cells, were
significantly inhibited upon anti-IFNg treatment (Figure 7d:
CXCL10: wt: 1±0.08, DEREGþNTN: 7.5±0.8, DEREG
NTNþDTx: 19.5±2.8, DEREG NTNþ aIFNg: 8±0.9,
DEREG NTNþDTx þ aIFNg: 11.3±0.4; T-bet: wt:
1±0.24, DEREGþNTN: 2.7±0.4, DEREG NTNþDTx:
7.9±0.9, DEREG NTNþ aIFNg: 2.1±0.35, DEREG
NTNþDTx þ aIFNg: 4.1±1.3; ***Po0.0001; *Po0.05).
Moreover, measurement of the systemic humoral anti-sheep
immune response in mouse serum indicated that the IFNg-
related IgG2a/c response was significantly inhibited in anti-
IFNg-treated Treg-depleted nephritic DEREG mice compared
with the nontreated ones (Figure 7e (optical density at
450 nm): wt: 0.17±0.01, DEREGþNTN: 0.39±0.03, DE-
REG NTNþDTx: 1.36±0.18, DEREG NTNþ aIFNg:
0.37±0.03, DEREG NTNþDTx þ aIFNg: 0.87±0.16;
***Po0.0001; *Po0.05). In contrast, concentrations of the
‘non-Th1-related’ antibodies IgG1 and IgG2b remained
unaffected (Figure 7e).
DISCUSSION
Tregs develop in the thymus in order to regulate auto-
immunity in the periphery. Upon inflammation, they
become activated and increase in number, either by
proliferation of thymus-derived naturally occurring natural
Tregs and/or by peripheral conversion of CD4þCD25
responder T cells to CD4þCD25þFoxP3þ Tregs.11 Here
we describe that upon induction of experimental crescentic
glomerulonephritis, frequency as well as absolute number of
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FoxP3þ Tregs increased substantially within renal tissue and
more weakly within spleen.
Depletion of Tregs by repetitive injections of DTx on day
–1 and day 3 upon NTN induction resulted in exacerbation of
glomerular crescent formation and mouse anti-sheep IgG
antibody production as well as in enhanced systemic and
renal IFNg production. However, depletion of Tregs only
during the heterologous phase of NTN nephritis, that is,
when antigen-specific priming is likely to occur in the
lymphoid tissue, failed to increase crescent formation
(Supplementary Figure S1B online). We observed similar
results by starting Treg depletion at the beginning of the
autologous phase (data not shown). Hence, it seems likely
that both Tregs that home in the lymphoid tissue and Tregs
that migrate into the inflamed kidney control glomerulone-
phritis. The enhanced IFNg response observed in the
aggravated phenotype correlated with an increase of macro-
phage/monocyte/DC and T-cell infiltration into periglomer-
ular and interstitial areas of the renal cortex. As Tregs were
depleted in this experimental setting, the infiltrating CD3þ
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12-myristate 13-acetate (PMA)/ionomycin. Intracellular cytokine production of IFNg and IL-17 was analyzed by flow cytometry.
Representative dot plots are depicted. Cells are gated on CD4þ T cells and numbers represent events in quadrants in percentage of all
gated events. (c) The frequencies of IFNg- and IL-17-producing renal CD4þ T cells were quantified (***Po0.0001). All analyses were
performed at day 7 after induction of NTN.
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T cells most likely consisted of activated effector T lympho-
cytes of which the CD4þ cells indeed produced substantially
increased amounts of IFNg whereas IL-17 production
remained unaffected, although glomerular injury in our
model is mediated by a Th1 as well as by a Th17 response.9,12
However, it seems noteworthy that the systemic release of
IL-17 detected in supernatants of splenocyte cultures was
significantly suppressed in the Treg-depleted group. In view
of the fact that Tregs also suppress maturation and function
of DCs,13 this can be explained by the observation that IL-12,
the major inducer of IFNg, decreases IL-17 production.14
Intriguingly, a recent publication also showed that Tregs from
patients with active pulmonary tuberculosis suppressed
IFNg production, whereas the Th17 response remained
unaffected.15 Taken together, the most dramatic effect of
Treg depletion observed in our study was aggravation of the
IFNg T-cell response. These results suggest that the observed
increase of frequency and absolute number of immunosup-
pressive Tregs during acute NTN regulates the systemic and
local inflammatory Th1 response.
Noteworthy, in our experiments DEREG mice followed
the equivalent characteristic features of NTN compared with
C57BL/6 wt mice. Furthermore, DTx neither caused renal
toxicity in wt or DEREG mice nor nonresponsiveness toward
itself,16 as PAS staining failed to show histopathological
alterations and DTx efficiently depleted Tregs as measured
4 days after the second injection, respectively.
Up to now, three reports dealt with suppressive effects of
Tregs in the planted antigen model of nephrotoxic serum
nephritis. Adoptive transfer of CD4þCD25þ Tregs protected
mice from nephritis induced by anti-glomerular basement
membrane rabbit serum. Measuring tissue levels of FoxP3
mRNA, the authors concluded that most of the adoptively
transferred Tregs migrated to secondary lymphoid organs but
not into the inflamed kidney.5 However, using FACS analysis
and quantitative immunohistochemistry, we could recently
demonstrate that adoptively transferred Tregs migrate into
the kidney as long as they express the chemokine receptor
CCR6,7 and CCR6 expression by adoptively transferred Tregs
was absolutely necessary for their protective effect. Hence,
together with the finding that Treg depletion only in the
heterologous phase failed to induce the aggravated pheno-
type, it seems that CD4þFoxP3þ Tregs have to accumulate
within the inflamed kidney, at least in dependence of CCR6,
in order to sufficiently suppress glomerulonephritis. Results
of the third report suggest that lymphoid homing of Tregs is a
prerequisite for downregulation of anti-glomerular basement
membrane nephritis.6 Our results presented here show that
in contrast to spleen, CD4þFoxP3þ Tregs substantially
increased within kidney during NTN nephritis in comparison
with normal frequency of B5% in healthy mice, and
depletion of these cells significantly correlated with aggrava-
tion of glomerulonephritis. The necessity of inflammatory
tissue-homing Tregs for suppression of inflammatory tissue
damage has also been observed in models of intestinal
inflammation17 and inflammatory liver injury.18 Taken
together, these data indicate that the anti-inflammatory
functions of Tregs in experimental glomerulonephritis take
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Figure 6 | Enhanced systemic Th1 immune response in
regulatory T cell (Treg)-depleted mice. (a) Cytokine secretion
of interferon-g (IFNg) and interleukin-17 (IL-17) in supernatants
of cultured splenocytes after treatment with sheep
immunoglobulin G (IgG) was measured by enzyme-linked
immunosorbent assay (ELISA; ***Po0.0001). (b) Circulating titers
of mouse anti-sheep total IgG and isotypes of IgG1, IgG2a/c, and
IgG2b at day 7 after induction of nephritis were measured by
ELISA in wild-type (wt) and DEREG (depletion of regulatory T cell)
mice without and with nephrotoxic nephritis (NTN) and diphtheria
toxin (DTx) treatment. Serum was diluted as indicated
(***Po0.0001, **Po0.01, *Po0.05).
Figure 7 |Attenuation of renal and systemic Th1 immune response upon neutralization of interferon-c (IFNc). (a) Quantification of
glomerular crescent formation in depleted or nondepleted nephritic DEREG (depletion of regulatory T cell) mice without or with
administration of anti-IFNg antibody (**Po0.01). (b) Blood urea nitrogen (BUN) levels were determined in nonnephritic wild-type (wt)
littermates and nephritic DEREG mice. (c) Renal single-cell suspensions from wt mice and nephritic DEREG mice±diphtheria toxin
(DTx)±aIFNg treatment were stimulated in vitro with phorbol 12-myristate 13-acetate (PMA)/ionomycin. Intracellular cytokine production
of IFNg was analyzed by flow cytometry. Representative dot plots are depicted. Cells are gated on CD4þ T cells and numbers represent
events in quadrants in percentage of all gated events. (d) Quantitative real-time PCR analysis of renal mRNA expression of CXCL10
(chemokine (C-X-C motif) ligand 10) and T-bet was performed in nephritic DEREG mice (±DTx;±aIFNg) and wt littermates (***Po0.0001,
*Po0.05). The mRNA levels are expressed as x-fold of nonnephritic wt controls. (e) Circulating titers of mouse anti-sheep total
immunoglobulin G (IgG) and isotypes of IgG1, IgG2a/c, and IgG2b were measured by enzyme-linked immunosorbent assay (ELISA) in
wt mice and DEREG nephrotoxic nephritis (NTN) mice with or without treatment of DTx and/or aIFNg. Serum was diluted as indicated
(***Po0.0001, **Po0.01, *Po0.05). All analyses were performed 7 days after NTN induction.
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place in the inflamed kidney itself and in the secondary
lymphatic organs such as the renal lymph nodes.
In addition to anti-glomerular basement membrane
nephritis,5 adoptively transferred Tregs have been shown to
prevent murine lupus nephritis.19 However, Treg cells did not
only suppress ‘immune-mediated’ glomerulonephritis, but
also ‘non-immune’ toxin-mediated kidney injury in the
adriamycin nephropathy model. In this model, polyclonal
CD4þCD25þ Tregs20 and, moreover, FoxP3-transduced T
cells,21 gd T cells, or alternatively activated macrophages3
were approved as efficient immunotherapy against renal
injury. As anti-inflammatory cytokines represent one critical
mechanism of regulatory immune cells including Tregs, these
findings support the concept that Tregs not only suppress
adaptive T-cell responses but also pathology driven by innate
immune mechanisms.22 Hence, the immunosuppressive
mechanisms by which Tregs suppress glomerulonephritis
resulting from different etiologies remain to be elucidated.
In patients with autoimmune kidney disease such as lupus
nephritis, decreased proportions of Tregs have been reported
to inversely correlate with clinical disease activity.23,24
However, several studies also reported unaltered or even
increased numbers of Tregs in lupus patients and positive
correlation with disease activity. Similar results were obtained
when the functional immunosuppressive activity of Tregs
from lupus patients was assessed. These divergent results can
be explained by the fact that in contrast to the murine system,
in humans FoxP3 is rather an activity marker for T cells than
a specific marker for Tregs. Although one can imagine that
Treg numbers and function are impaired during chronic
disease, our results shown here demonstrate that during
acute glomerulonephritis, Treg numbers initially increased
and their immunosuppressive function was at least as effec-
tive as the function of Tregs from healthy controls.
In conclusion, depletion of Tregs exacerbated acute kidney
inflammation and glomerular injury, an effect that was most
likely mediated by IFNg, as IFNg production by intrarenal
and splenic CD4þ T cells substantially increased and anti-
IFNg antibodies significantly suppressed this effect. Hence,
this study might be useful to evaluate novel therapeutic
approaches by modulating Tregs in order to suppress Th1
immune responses in kidney diseases.
MATERIALS AND METHODS
Animals
Male DEREG mice expressing the DTx receptor and GFP under
control of the FoxP3 promoter8 and sex/age-matched (8–10 weeks
old) C57BL/6 wt controls were obtained from animal facilities of
the Universita¨tsklinikum Hamburg-Eppendorf. Animals received
humane care according to guidelines of the National Institute of
Health in Germany. Experiments were approved by the institutional
review board ‘Beho¨rde fu¨r Soziales, Familie, Gesundheit und
Verbraucherschutz’ (Hamburg).
Animal treatment and functional studies
Nephrotoxic serum nephritis was induced in C57BL/6 wt and DEREG
mice by intraperitoneal injection of 500ml of nephrotoxic sheep serum
per mouse. Controls were injected intraperitoneally with an equal
amount of nonspecific sheep IgG. To deplete Tregs in DEREG mice,
DTx (1mg per mouse) was injected intraperitoneally either twice 24 h
before NTN induction and 3 days upon NTN induction or only once
24 h before NTN induction. Rat anti-mouse IFNg monoclonal
antibody (XGM1.2; see Mumberg et al.25); 500mg/mouse) or rat IgG
was injected intraperitoneally 24 h before NTN induction. Blood
samples for measurement of blood urea nitrogen and assessment of
systemic antibody response were obtained at the time of killing.
For urine sample collection, mice were housed in metabolic cages
for 6 h. Urinary creatinine and blood urea nitrogen were measured
by standard laboratory methods. Albuminuria was determined
by standard ELISA analysis (mice-albumin kit; Bethyl Laboratories,
Montgomery, TX).
Real-time quantitative reverse transcription-PCR analysis
Total RNA was reversely transcribed followed by quantitative reverse
transcription-PCR using BIORAD CFX96 real-time system and
ABsoluteQPCR SYBR mix (Fisher Scientific GmbH, Schwerte,
Germany). Primer pairs were used as described previously.7–9 Relative
mRNA levels were calculated after normalization to 18S rRNA using the
CFX96 Manager software (Bio-Rad Laboratories, Munich, Germany).
Morphological examinations
Light microscopy and immunohistochemistry were performed by
routine procedures. Crescent formation was assessed in 30 glomeruli
per mouse in a blinded fashion in PAS-stained paraffin sections.
Tubulointerstitial injury was estimated by point counting in four
independent areas of renal cortex per mouse in 200-fold magnifica-
tion.7 Paraffin-embedded sections (2 mm) were either stained with
an antibody directed against the pan-T-cell marker CD3 (A0452;
Dako, Hamburg, Germany), the Treg transcription factor FoxP3
(FJK-16s; eBioscience, San Diego, CA), the macrophage/monocyte/
DC marker F4/80 (BM8; BMA, Augst, Switzerland), and sheep
or mouse IgG (Jackson ImmunoResearch Europe, Newmarket, UK).
Tissue sections were developed with the Vectastain ABC-AP kit
(Vector Laboratories, Burlingame, CA). For FoxP3 staining, tissue
sections were incubated with a polyclonal rabbit anti-rat secondary
antibody (Dako) and developed with the ZytoChemPlus (AP)
Polymer Kit (Zytomed Systems, Berlin, Germany). CD3þ cells in 20
glomerular cross-sections and F4/80þ and CD3þ cells in 20
tubulointerstitial high power fields ( 400) per kidney were
counted in a blinded fashion. For quantification of FoxP3þ Tregs,
at least seven low power fields ( 100) were counted. Glomerular
mouse IgG deposition was scored from 0 to 3 in 20 glomeruli per
mouse as previously described.7
Antigen-specific humoral immune response
Mouse anti-sheep IgG antibody titers were measured by ELISA using
sera collected 7 days after induction of nephritis.7,9,26 In brief, ELISA
microtiter plates were coated with 100 ml sheep IgG (100 mg/ml;
Sigma, St Louis, MO) in carbonate–bicarbonate buffer overnight at
4 1C. After blocking with 1% bovine serum albumin in Tris-buffered
saline (Sigma), plates were incubated with serial dilutions of
mouse serum for 1 h at room temperature. Bound mouse IgG
was detected using peroxidase-conjugated goat anti-mouse IgG
(Biozol, Eching, Germany), TMB peroxidase substrate, and absorbance
readings (450 nm). Lack of crossreactivity of the secondary antibody
with sheep IgG was demonstrated by omitting the primary antibody.
The bound mouse immunoglobulin isotypes were detected using
peroxidase-conjugated rabbit anti-mouse IgG, IgG1, IgG2a/c, and
IgG2b antibodies (Zymed-Invitrogen, Karlsruhe, Germany).
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Leukocyte isolation from various tissues
Previously described methods for leukocyte isolation from murine
kidneys were used.7,26 In brief, kidneys were finely minced and
digested for 45 min at 37 1C with 0.4 mg/ml collagenase D (Roche,
Mannheim, Germany) and 0.01 mg/ml DNAse I in Dulbecco’s
modied Eagle’s medium (Roche) supplemented with 10% heat-
inactivated fetal calf serum (Invitrogen, Darmstadt, Germany). Cell
suspensions were sequentially filtered through 70 and 40 mm
nylon meshes and washed with Hank’s balanced salt solution
without Ca2þ and Mg2þ (Invitrogen). Single-cell suspensions were
separated using Percoll density gradient (70 and 40%) centrifuga-
tion. Single-cell suspensions of spleens were prepared according to
standard laboratory procedures. In brief, tissue was passed through
70 and 40 mm nylon meshes before erythrocyte lysis. Subsequently,
cells were washed several times with Hank’s balanced salt solution
and resuspended in RPMI-1640 with 10% fetal calf serum. Viability
of the cells was assessed by Trypan blue staining before flow
cytometry.
Flow cytometry
Leukocytes were stained using a standard protocol. For T-cell
differentiation, isolated cells were stained with anti-CD3 (APC;
eBioscience), anti-CD4 (APC-AlexaFluor750), and anti-CD45
(PerCP; both from BD Biosciences, Franklin Lakes, NJ) upon a
blocking step. Staining of intracellular IFNg and IL-17 was
performed as described previously.12 In brief, splenocytes or renal
leukocytes were stimulated with phorbol 12-myristate 13-acetate
(50 ng/ml; Sigma) and ionomycin (1 mg/ml; Calbiochem-Merck,
Darmstadt, Germany) for 5 h. After 30 min of incubation, Brefeldin
A (10mg/ml; Sigma) was added. After several washing steps and
staining of cell surface markers, cells were permeabilized using
Cytofix/Cytoperm (BD Biosciences). Subsequently, intracellular
staining was performed using rat anti-mouse IFNg and IL-17
antibodies (V450 or PE; BD Biosciences) and an anti-FoxP3
antibody (eBioscience). Data were recorded using BD LSRII Flow
Cytometry system and BD FACSDiva software.
Isolation and culture of splenic CD4þCD25þ Tregs and
responder T cells
Spleens were excised from C57BL/6 wt 8 days after induction of
NTN, and from healthy controls and passed through 100 mm nylon
meshes. Sorting procedures were carried out by MACS according to
the manufacturers’ instructions (MACS CD4þ T-Cell-Isolation Kit;
Miltenyi Biotec, Bergisch-Gladbach, Germany). Briefly, CD4þ T
cells were enriched using a biotinylated antibody cocktail depleting
all other blood cell types and anti-biotin microbeads. CD4þCD25þ
T cells were isolated by positive selection using phycoerythrin-
labeled anti-CD25 monoclonal antibody and anti-phycoerythrin
microbeads. Purity and intracellular FoxP3 expression was con-
trolled by flow cytometry. Next, 1 105 wt responder T cells
(CD4þCD25) isolated from healthy mice were cultured alone or
with 1 105 CD4þCD25þ Tregs from nephritic wt or healthy
controls for 72 h in 96-well plates precoated with anti-CD3
monoclonal antibody (5 mg/ml; clone 145–2C11; BD Biosciences).
Cytokine concentrations were measured in supernatants by ELISA.
Statistical analysis
Results are expressed as mean±s.e.m. Differences between indivi-
dual experimental groups were compared by Student’s t-test. In case
of multiple comparisons, one-way analysis of variance with post
analysis by Tukey–Kramer test was used. Experiments that did not
yield enough independent data for statistical analysis due to the
experimental setup were repeated at least three times.
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